scanX
Home
Caplin Point Laboratories

Caplin Point Laboratories

2,049.65
+25.35
(1.25%)
Market Cap
15,579.74 Cr
EPS
60.19
PE Ratio
29.85
Dividend Yield
0.25 %
Industry
Healthcare
52 Week High
2,641.00
52 Week low
1,225.00
PB Ratio
6.05
Debt to Equity
0.00
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
 1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
Divis Laboratories
 5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
Cipla
 1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
Torrent Pharmaceuticals
 3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
Dr Reddys Laboratories
 1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
Mankind Pharma
 2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
Zydus Life Science
 899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
Lupin
 1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
Aurobindo Pharma
 1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
Abbott
 29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
15.65 %
Net Income Growth
22.39 %
Cash Flow Change
17.33 %
ROE
-0.56 %
ROCE
1.57 %
EBITDA Margin (Avg.)
7.57 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
64
71
78
81
84
87
98
105
122
127
135
144
146
148
163
167
190
197
234
239
235
247
270
280
288
310
312
336
351
360
376
386
401
407
431
453
471
478
504
524
Expenses
48
51
57
57
61
63
68
71
75
78
82
91
95
93
100
101
123
125
156
160
161
169
181
191
193
208
202
225
239
244
254
263
265
269
273
293
308
307
318
331
EBITDA
16
20
22
24
22
24
30
34
48
50
53
53
52
55
63
66
67
72
78
78
73
78
89
90
95
102
110
111
111
116
122
124
135
139
158
160
163
170
185
194
Operating Profit %
24 %
27 %
27 %
29 %
25 %
26 %
29 %
31 %
37 %
37 %
38 %
36 %
34 %
36 %
36 %
36 %
35 %
35 %
31 %
30 %
25 %
30 %
33 %
31 %
31 %
31 %
33 %
31 %
29 %
30 %
29 %
29 %
32 %
32 %
34 %
33 %
32 %
33 %
34 %
33 %
Depreciation
1
3
2
3
3
3
3
3
5
4
4
5
6
5
6
6
7
7
7
8
8
9
9
9
10
12
12
12
11
11
12
11
11
11
12
14
16
16
17
16
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
15
16
20
21
20
21
27
31
43
46
49
49
45
49
57
60
61
64
71
70
65
69
80
80
85
90
98
99
100
105
110
112
124
127
146
145
146
154
169
177
Tax
4
4
5
5
4
5
5
7
9
10
13
11
10
12
14
14
11
14
13
11
16
14
17
14
17
18
21
19
19
19
18
14
23
23
30
26
25
30
38
37
Net Profit
11
13
14
16
16
16
22
24
33
36
36
38
35
37
44
46
50
50
57
59
49
55
63
66
68
72
77
79
81
86
92
97
101
104
116
120
121
125
131
140
EPS in ₹
7.02
8.40
1.86
10.66
10.31
10.55
14.85
3.15
4.41
4.81
4.71
4.97
4.76
4.95
6.21
6.06
6.58
6.64
7.58
7.74
6.46
7.21
7.52
8.52
8.78
9.37
9.91
9.90
10.43
11.21
12.09
12.86
13.45
13.62
15.13
15.44
16.01
16.32
17.22
18.28
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
229
267
358
501
743
1,126
1,364
1,736
2,191
2,698
Fixed Assets
113
144
152
170
227
273
305
287
280
453
Current Assets
82
119
179
304
494
823
1,015
1,298
1,552
1,893
Capital Work in Progress
31
0
3
15
10
20
14
18
221
117
Investments
0
0
17
47
70
61
11
89
281
376
Other Assets
85
123
186
269
436
772
1,033
1,343
1,410
1,753
Total Liabilities
229
267
358
501
743
1,126
1,364
1,736
2,191
2,698
Current Liabilities
125
125
113
109
86
144
143
208
268
331
Non Current Liabilities
10
14
20
28
23
25
17
19
16
20
Total Equity
94
128
225
364
633
957
1,203
1,510
1,907
2,347
Reserve & Surplus
78
113
210
349
514
716
954
1,252
1,649
2,084
Share Capital
15
15
15
15
15
15
15
15
15
15
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
19
23
25
-14
74
70
215
-81
27
-39
Investing Activities
-23
-6
-36
-69
-100
-54
-30
-377
-216
-319
Operating Activities
50
42
68
67
83
45
269
337
271
318
Financing Activities
-9
-14
-7
-12
90
80
-24
-41
-28
-38
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
69.03 %
69.03 %
69.03 %
68.91 %
68.89 %
68.88 %
68.88 %
68.80 %
70.66 %
70.63 %
70.63 %
70.62 %
70.62 %
70.56 %
70.56 %
70.56 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.09 %
2.85 %
3.34 %
3.37 %
3.70 %
4.86 %
DIIs
1.28 %
1.44 %
1.14 %
1.16 %
1.20 %
1.07 %
1.12 %
1.12 %
0.65 %
0.26 %
0.20 %
0.43 %
1.09 %
1.49 %
1.84 %
2.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
22.94 %
21.69 %
20.93 %
20.79 %
20.79 %
20.76 %
19.00 %
18.91 %
18.73 %
18.57 %
18.31 %
18.36 %
17.59 %
17.50 %
17.12 %
15.77 %
Others
6.75 %
7.85 %
8.90 %
9.13 %
9.12 %
9.28 %
11.00 %
11.17 %
9.96 %
10.53 %
7.77 %
7.74 %
7.36 %
7.08 %
6.78 %
6.70 %
No of Share Holders
68,076
69,524
83,462
85,577
83,829
84,868
84,538
82,687
82,146
78,956
78,068
79,438
81,409
80,411
96,123
92,702

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1.5 2 2.2 2.5 3 4 4.5 5 0.00
Dividend Yield (%) 0.00 0.26 0.5 0.78 0.62 0.44 0.68 0.34 0.25 0.00

Corporate Action

Technical Indicators

Bearish
0
Neutral
0
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Technical Screeners
Candlestick Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.